Scandinavian ChemoTech AB Class B (SE:CMOTEC.B)
:CMOTEC.B
Want to see SE:CMOTEC.B full AI Analyst Report?
Total Valuation
Scandinavian ChemoTech AB Class B has a market cap or net worth of kr101.56M. The enterprise value is kr89.40M.
Market Capkr101.56M
Enterprise Valuekr89.40M
Share Statistics
Scandinavian ChemoTech AB Class B has 23,802,313 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23,802,313
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Scandinavian ChemoTech AB Class B’s return on equity (ROE) is -2.53 and return on invested capital (ROIC) is -197.80%.
Return on Equity (ROE)-2.53
Return on Assets (ROA)-0.61
Return on Invested Capital (ROIC)-197.80%
Return on Capital Employed (ROCE)-1.98
Revenue Per Employee4.09M
Profits Per Employee-2.15M
Employee Count3
Asset Turnover0.93
Inventory Turnover6.65
Valuation Ratios
The current PE Ratio of Scandinavian ChemoTech AB Class B is ―. Scandinavian ChemoTech AB Class B’s PEG ratio is 0.35.
PE Ratio―
PS Ratio9.82
PB Ratio37.86
Price to Fair Value37.86
Price to FCF-28.84
Price to Operating Cash Flow-25.94
PEG Ratio0.35
Income Statement
In the last 12 months, Scandinavian ChemoTech AB Class B had revenue of 12.29M and earned -8.06M in profits. Earnings per share was -0.34.
Revenue12.29M
Gross Profit-6.30M
Operating Income-6.30M
Pretax Income-8.06M
Net Income-8.06M
EBITDA-4.33M
Earnings Per Share (EPS)-0.34
Cash Flow
In the last 12 months, operating cash flow was -9.48M and capital expenditures 0.00, giving a free cash flow of -9.48M billion.
Operating Cash Flow-9.48M
Free Cash Flow-9.48M
Free Cash Flow per Share-0.40
Dividends & Yields
Scandinavian ChemoTech AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.59
52-Week Price Change79.73%
50-Day Moving Average3.64
200-Day Moving Average3.98
Relative Strength Index (RSI)49.54
Average Volume (3m)54.14K
Important Dates
Scandinavian ChemoTech AB Class B upcoming earnings date is May 20, 2026, TBA (Confirmed).
Last Earnings DateMar 3, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Scandinavian ChemoTech AB Class B as a current ratio of 0.91, with Debt / Equity ratio of 0.00%
Current Ratio0.91
Quick Ratio0.63
Debt to Market Cap0.00
Net Debt to EBITDA0.85
Interest Coverage Ratio-3.96
Taxes
In the past 12 months, Scandinavian ChemoTech AB Class B has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Scandinavian ChemoTech AB Class B EV to EBITDA ratio is -27.01, with an EV/FCF ratio of -27.96.
EV to Sales9.52
EV to EBITDA-27.01
EV to Free Cash Flow-27.96
EV to Operating Cash Flow-31.23
Balance Sheet
Scandinavian ChemoTech AB Class B has kr517.00K in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr517.00K billion.
Cash & Marketable Securitieskr517.00K
Total Debtkr0.00
Net Cashkr517.00K
Net Cash Per Sharekr0.02
Tangible Book Value Per Share-kr0.03
Margins
Gross margin is 52.64%, with operating margin of -51.30%, and net profit margin of -65.58%.
Gross Margin52.64%
Operating Margin-51.30%
Pretax Margin-65.58%
Net Profit Margin-65.58%
EBITDA Margin-35.24%
EBIT Margin-51.30%
Analyst Forecast
The average price target for Scandinavian ChemoTech AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast87.10%
EPS Growth Forecast45.96%